Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML)
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Lenguaje: | English |
| Publicado: |
American Society of Clinical Oncology
2022
|
| _version_ | 1826313409007714304 |
|---|---|
| author | Dinardo, CD Montesinos, P Schuh, AC Papayannidis, C Vyas, P Wei, AH Zeidan, AM Chen, C Lord-Bessen, J Yu, P Shi, L Guo, S Bluemmert, I Yu, X Hasan, M Martin Regueira, P De Botton, S |
| author_facet | Dinardo, CD Montesinos, P Schuh, AC Papayannidis, C Vyas, P Wei, AH Zeidan, AM Chen, C Lord-Bessen, J Yu, P Shi, L Guo, S Bluemmert, I Yu, X Hasan, M Martin Regueira, P De Botton, S |
| author_sort | Dinardo, CD |
| collection | OXFORD |
| description | |
| first_indexed | 2024-09-25T04:14:17Z |
| format | Journal article |
| id | oxford-uuid:b327eb0e-cd02-4db8-bfa9-c2cf0e4f93f0 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-09-25T04:14:17Z |
| publishDate | 2022 |
| publisher | American Society of Clinical Oncology |
| record_format | dspace |
| spelling | oxford-uuid:b327eb0e-cd02-4db8-bfa9-c2cf0e4f93f02024-07-09T12:11:51ZHealth-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML)Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b327eb0e-cd02-4db8-bfa9-c2cf0e4f93f0EnglishSymplectic ElementsAmerican Society of Clinical Oncology2022Dinardo, CDMontesinos, PSchuh, ACPapayannidis, CVyas, PWei, AHZeidan, AMChen, CLord-Bessen, JYu, PShi, LGuo, SBluemmert, IYu, XHasan, MMartin Regueira, PDe Botton, S |
| spellingShingle | Dinardo, CD Montesinos, P Schuh, AC Papayannidis, C Vyas, P Wei, AH Zeidan, AM Chen, C Lord-Bessen, J Yu, P Shi, L Guo, S Bluemmert, I Yu, X Hasan, M Martin Regueira, P De Botton, S Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML) |
| title | Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML) |
| title_full | Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML) |
| title_fullStr | Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML) |
| title_full_unstemmed | Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML) |
| title_short | Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML) |
| title_sort | health related quality of life hrqol with enasidenib versus conventional care regimens in older patients with late stage mutant idh2 relapsed or refractory acute myeloid leukemia r r aml |
| work_keys_str_mv | AT dinardocd healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT montesinosp healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT schuhac healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT papayannidisc healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT vyasp healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT weiah healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT zeidanam healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT chenc healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT lordbessenj healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT yup healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT shil healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT guos healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT bluemmerti healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT yux healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT hasanm healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT martinregueirap healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml AT debottons healthrelatedqualityoflifehrqolwithenasidenibversusconventionalcareregimensinolderpatientswithlatestagemutantidh2relapsedorrefractoryacutemyeloidleukemiarraml |